These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 15153695)
1. Salivary enhancement therapies. Fox PC Caries Res; 2004; 38(3):241-6. PubMed ID: 15153695 [TBL] [Abstract][Full Text] [Related]
2. Management of xerostomia and salivary gland hypofunction. Ram S; Kumar S; Navazesh M J Calif Dent Assoc; 2011 Sep; 39(9):656-9. PubMed ID: 22034800 [TBL] [Abstract][Full Text] [Related]
3. Patient selection criteria for electrostimulation of salivary production in the treatment of xerostomia secondary to Sjogren's syndrome. Erlichman M Health Technol Assess Rep; 1990; (8):1-7. PubMed ID: 1369638 [TBL] [Abstract][Full Text] [Related]
4. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome. Khurshudian AV Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025 [TBL] [Abstract][Full Text] [Related]
5. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Nieuw Amerongen AV; Veerman EC Support Care Cancer; 2003 Apr; 11(4):226-31. PubMed ID: 12673460 [TBL] [Abstract][Full Text] [Related]
7. Effect of cevimeline on salivary components in patients with Sjögren syndrome. Suzuki K; Matsumoto M; Nakashima M; Takada K; Nakanishi T; Okada M; Ohsuzu F Pharmacology; 2005 May; 74(2):100-5. PubMed ID: 15722648 [TBL] [Abstract][Full Text] [Related]
8. Salivary hypofunction: An update on therapeutic strategies. Salum FG; Medella-Junior FAC; Figueiredo MAZ; Cherubini K Gerodontology; 2018 Dec; 35(4):305-316. PubMed ID: 29956369 [TBL] [Abstract][Full Text] [Related]
9. Salivary gland dysfunction: a review of systemic therapies. Grisius MM Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):156-62. PubMed ID: 11505261 [TBL] [Abstract][Full Text] [Related]
10. A new medication for treatment of dry mouth in Sjögren's syndrome. al-Hashimi I; Taylor SE Tex Dent J; 2001 Apr; 118(3):262-6. PubMed ID: 11404944 [TBL] [Abstract][Full Text] [Related]
11. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation. Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361 [TBL] [Abstract][Full Text] [Related]
12. Effect of Pilocarpine on impaired salivary secretion in patients with Sjögren's syndrome. Jorkjend L; Bergenholtz A; Johansson AK; Johansson A Swed Dent J; 2008; 32(2):49-56. PubMed ID: 18700333 [TBL] [Abstract][Full Text] [Related]
13. Salivary enhancement: current status and future therapies. Atkinson JC; Baum BJ J Dent Educ; 2001 Oct; 65(10):1096-101. PubMed ID: 11699983 [TBL] [Abstract][Full Text] [Related]
14. Salivary hypofunction and xerostomia: diagnosis and treatment. Atkinson JC; Grisius M; Massey W Dent Clin North Am; 2005 Apr; 49(2):309-26. PubMed ID: 15755407 [TBL] [Abstract][Full Text] [Related]
15. Management of salivary hypofunction during and after radiotherapy. Shiboski CH; Hodgson TA; Ship JA; Schiødt M Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S66.e1-19. PubMed ID: 17379158 [TBL] [Abstract][Full Text] [Related]